Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Alendronate and ibandronate af...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
Bibliographic Details
Main Authors:
Mabilleau, G
,
Kwaasi, A
,
Tsoumpra, M
,
Sabokbar, A
,
Dunford, J
,
Ebetino, F
,
Russell, R
Format:
Conference item
Published:
2011
Holdings
Description
Similar Items
Staff View
Similar Items
BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
by: Mabilleau, G, et al.
Published: (2010)
Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
by: Kavanagh, K, et al.
Published: (2006)
Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis
by: Brounais-Le Royer, B, et al.
Published: (2012)
Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
by: NP Somasundaram, et al.
Published: (2012-03-01)
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01)